5/6/2026

speaker
Operator
Conference Operator

Good day, ladies and gentlemen. Thank you for standing by. Welcome to today's conference call to discuss LifeVantage's third quarter of fiscal 2026 results. At this time, all participants are in a listen-only mode. Following the formal remarks, we will conduct a question and answer session. Instructions will be provided at that time for you to queue up. Hosting today's conference will be Reid Anderson with ICR. As a reminder, today's conference is being recorded. And now I would like to turn the conference over to Mr. Anderson. Please go ahead, sir.

speaker
Reid Anderson
Host, ICR

Thank you. Good afternoon and welcome to LifeVantage Corporation's conference call to discuss results for the third quarter of fiscal 2026. On the call today from LifeVantage are Michael Beindorf, Interim Chief Executive Officer, Carl Alray, Chief Financial Officer, and Kristen Cunningham, Chief Sales Officer. By now, everyone should have access to the earnings release, which went out this afternoon at approximately 4.05 p.m. Eastern Time. If you have not received the release, it is available on the investor relations portion of LifeVantage's website at www.lifevantage.com. This call is being webcast, and a replay will be available on the company's website as well. Before we begin, we would like to remind everyone that our prepared remarks contain forward-looking statements, and management may make additional forward-looking statements in response to your questions. These statements do not guarantee future performance, and therefore undue reliance should not be placed upon them. These statements are based on current expectations of the company's management and involve inherent risks and uncertainties, including those identified in the risk factors section of LifeVantage's most recently filed forms 10-K and 10-Q. Please note that during today's call, we will discuss non-GAAP financial measures, including results on an adjusted basis. Management believes these financial measures can facilitate a more complete analysis and greater transparency into LifeVantage's ongoing results of operations particularly when comparing underlying operating results from period to period. We've included a reconciliation of these non-GAAP measures with today's release. This call also contains time-sensitive information that is accurate only as of the date of the slide broadcast, May 6, 2026. LifeVantage assumes no obligation to update any forward-looking projections that may be made in today's release or call. Now I will turn the call over to Michael Beindorf, Interim CEO of LifeVantage.

speaker
Michael Beindorf
Interim Chief Executive Officer

Thank you, Reid. Good afternoon, and thank you all for joining us today. For those of you I haven't had the opportunity to meet, let me briefly introduce myself. I've had the privilege of serving on the LifeVantage Board of Directors since 2012, which gives me over 14 years of insight into this company's evolution, challenges, and the tremendous opportunities that we have in front of us. I've spent my career building consumer brands across a variety of business environments, including the Coca-Cola Company, Visa, and Planet Rx, amongst some others. Before we dive into our quarterly results today, I want to take just a moment to recognize Steve Fyfe, who retired as our president and CEO on April 30th. Steve's tenure at LifeVantage has been absolutely transformational. His strategic vision and his relentless focus on operational excellence have been instrumental in modernizing our business model strengthening our financial position, and laying the foundation for the future. So on behalf of the entire board in the organization, I want to thank him for his leadership, and I want to wish him the very best in his retirement. Now, you might ask why a long-serving board member would step into an interim operating role, and the answer to that is pretty simple. I believe deeply in LifeVantage's products, its people, and its potential. And my 14 years of board service, I think, give me a pretty unique perspective on what makes this company special. I'm excited about our product portfolio, from our flagship ProTandem family to innovations like TrueScience Liquid Collagen, the MindBody GLP-1 system, and our comprehensive gut activator, P84. These products represent genuine innovation in cellular health activation and are all backed by rigorous scientific validations. But what truly gets me excited is our passionate consultant community. Having spent almost my entire career building consumer brands, I deeply appreciate the power of authentic advocacy. Our consultants understand the uniqueness of our products and the deep scientific validation behind them. And they deliver this information and these products to people every day. they share their personal health journeys, and they create genuine entrepreneurial opportunities. That's a combination that is both powerful and sustainable. You know, our most recent Momentum Academy in Las Vegas was a great example of this. It perfectly captured the energy and the potential of our consultant community. It was centered around the theme of breakthrough, and this three-day immersive experience brought together our independent consultants and from across the country for powerful leadership training, business building strategies, and meaningful connection with each other. Among other things during the conference, the company announced the VIP bonus, our first ever 12-month volume growth incentive program for consultants. This program will handsomely reward consultants who meet their growth goals, and we believe the program can be a game changer, not only as a catalyst for growth, but also in terms of leadership development. In addition to incentivizing growth, the program is designed to identify and elevate consultants who demonstrate the leadership behaviors associated with long-term success. We think that by rewarding these behaviors, we'll build a stronger leadership pipeline and align our field organization around what is required to improve the company's long-term growth trajectory. The passion, the clarity, and the commitment that I witnessed in Las Vegas reinforced my confidence in our community's strength and our company's future. Now, before Carl details our Q3 results, I want to provide a brief high-level perspective on where we stand today and where this enterprise is headed in the future. The direct selling business continues to evolve, and Light Vantage has been proactive in adapting our business model to meet the changing consumer preferences and market dynamics. We've invested in digital capabilities, upgraded our consultant compensation plan, we've enhanced our consultant tools and support systems, and we've continued to innovate our product offerings to address emerging health and wellness trends. And these investments in our future are continuing. As we told you in February, we're making a significant investment in upgrading our e-commerce platform. The launch of Shopify, along with a totally revamped and upgraded back office system will dramatically improve both our customers and our consultants' e-commerce experience with LifeVantage from end to end. We plan to start launching Shopify later this year, and we're excited about the prospects as we roll the Shopify launch through our markets. In addition, our business fundamentals are solid. We have a clean balance sheet, no debt, and cash reserves that give us flexibility. Looking ahead, we see significant opportunities. The health and wellness market continues to expand, and our unique positioning in nutrigenomics gives us credibility and we think differentiates us in a crowded marketplace. We remain committed to operational excellence, strategic execution, and delivering value for all stakeholders. With that, let me turn it over to Carl to take you through our financial results.

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-